US Stock MarketDetailed Quotes

ASTELLAS PHARMA (ALPMF)

Watchlist
  • 15.850
  • 0.0000.00%
15min DelayClose Aug 24 14:21 ET
28.40BMarket Cap15.55P/E (TTM)

ASTELLAS PHARMA (ALPMF) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: JPY
2026/Q1
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
2021/Q1
2020/Q4
2020/Q3
Total Revenue as Reported
+6.91%505.79B
+26.17%473.12B
+17.04%414.60B
+4.91%421.93B
+3.09%392.15B
-1.78%374.99B
+16.58%354.25B
+18.07%402.18B
+16.86%380.39B
+17.06%381.79B
-1.54%303.87B
+4.67%340.63B
+5.51%325.52B
+6.25%326.14B
-1.18%308.62B
-3.74%325.43B
-2.47%308.51B
-8.13%306.97B
+3.65%312.31B
-5.55%338.07B
Total Operating Revenue
+6.91%505.79B
+26.17%473.12B
+17.04%414.60B
+4.91%421.93B
+3.09%392.15B
-1.78%374.99B
+16.58%354.25B
+18.07%402.18B
+16.86%380.39B
+17.06%381.79B
-1.54%303.87B
+4.67%340.63B
+5.51%325.52B
+6.25%326.14B
-1.18%308.62B
-3.74%325.43B
-2.47%308.51B
-8.13%306.97B
+3.65%312.31B
-5.55%338.07B
Cost of Revenue
+4.05%94.83B
+32.18%91.14B
+17.58%73.23B
+1.98%75.90B
+18.52%74.41B
-22.42%68.95B
+5.71%62.28B
+7.30%74.42B
+0.44%62.78B
+42.81%88.87B
+1.01%58.92B
+1.72%69.36B
+4.35%62.50B
+4.32%62.23B
+5.86%58.33B
-17.62%68.19B
-12.38%59.90B
-15.40%59.65B
-14.36%55.10B
-1.67%82.77B
Gross Profit
+7.59%410.97B
+24.82%381.99B
+16.92%341.37B
+5.58%346.04B
+0.04%317.74B
+4.48%306.04B
+19.19%291.97B
+20.82%327.76B
+20.76%317.61B
+10.99%292.92B
-2.13%244.96B
+5.45%271.27B
+5.79%263.02B
+6.71%263.91B
-2.69%250.29B
+0.76%257.24B
+0.26%248.62B
-6.19%247.32B
+8.54%257.21B
-6.74%255.30B
Operating Expense
-4.71%318.42B
+28.04%334.17B
+13.86%387.27B
+23.00%327.17B
+38.16%320.95B
+0.27%260.99B
+32.24%340.12B
+22.06%266.00B
+11.17%232.30B
+14.11%260.29B
-6.29%257.20B
+18.02%217.92B
-6.01%208.96B
+22.33%228.12B
+9.17%274.46B
+3.12%184.65B
+37.07%222.32B
+0.36%186.47B
+24.51%251.40B
-6.12%179.06B
Selling and Admin Expenses
-4.78%197.00B
+23.01%206.88B
+21.25%193.15B
+22.38%199.50B
+15.99%179.28B
+9.64%168.18B
+11.85%159.30B
+19.94%163.02B
+15.86%154.56B
+11.88%153.40B
+0.81%142.42B
+12.41%135.91B
+9.92%133.40B
+13.52%137.11B
-3.05%141.27B
-5.18%120.91B
+11.75%121.36B
+2.81%120.78B
+8.36%145.72B
+2.62%127.51B
-General & Admin Expense
-4.78%197.00B
+23.01%206.88B
+21.25%193.15B
+22.38%199.50B
+15.99%179.28B
+9.64%168.18B
+11.85%159.30B
+19.94%163.02B
+15.86%154.56B
+11.88%153.40B
+0.81%142.42B
+12.41%135.91B
+9.92%133.40B
+13.52%137.11B
-3.05%141.27B
-5.18%120.91B
+11.75%121.36B
+2.81%120.78B
+8.36%145.72B
+2.62%127.51B
Research & Development
-17.42%71.70B
+34.41%86.82B
+11.10%77.85B
+11.23%74.39B
+18.70%77.36B
-12.72%64.59B
+2.51%70.08B
+14.14%66.88B
+7.28%65.17B
+26.91%74.01B
+22.80%68.36B
+2.57%58.59B
+11.64%60.75B
+1.79%58.31B
-13.66%55.67B
+4.27%57.12B
+5.72%54.41B
+7.07%57.29B
+9.79%64.47B
+8.71%54.78B
-Depreciation & Amortization
-6.36%32.77B
+285.88%34.99B
+252.48%32.65B
+252.34%32.44B
+167.43%24.67B
-15.61%9.07B
+15.26%9.26B
+17.02%9.21B
+43.75%9.22B
+80.19%10.75B
+24.22%8.04B
+36.95%7.87B
+12.68%6.42B
+1.84%5.96B
+12.96%6.47B
+35.59%5.75B
+41.57%5.69B
-18.43%5.86B
-34.36%5.73B
-51.96%4.24B
Other Operating Expenses
+105.54%21.33B
-54.99%10.38B
-18.29%83.84B
-16.34%23.41B
+1106.04%42.94B
-40.00%23.06B
+107.59%102.61B
+50.26%27.98B
-67.16%3.56B
+41.66%38.44B
-31.00%49.43B
+292.29%18.62B
-75.41%10.84B
+465.27%27.13B
+120.07%71.64B
+1200.55%4.75B
+5218.82%44.09B
-60.57%4.80B
+3152.05%32.55B
-97.90%365.00M
Operating Profit
+93.52%92.54B
+6.13%47.82B
+4.67%-45.90B
-69.45%18.87B
-103.77%-3.22B
+38.09%45.06B
-293.17%-48.14B
+15.77%61.76B
+57.80%85.31B
-8.86%32.63B
+49.32%-12.25B
-26.51%53.35B
+105.56%54.06B
-41.16%35.80B
-515.58%-24.16B
-4.78%72.60B
-69.34%26.30B
-21.81%60.84B
-83.42%5.81B
-8.18%76.24B
Net Non-Operating Interest Income (Expense)
-2511.73%-4.23B
-115.34%-162.00M
-116.67%-62.00M
-1.23%-1.65B
-94.90%105.00M
+171.89%1.06B
-88.26%372.00M
-84.18%-1.63B
+349.94%2.06B
-465.00%-1.47B
-29.83%3.17B
-134.86%-885.00M
-129.45%-823.00M
+54.94%-260.00M
+2787.50%4.52B
+18.70%2.54B
+5181.82%2.80B
-3.22%-577.00M
-110.51%-168.00M
+6.84%2.14B
Non-Operating Interest Income
-61.53%1.67B
+14.75%4.33B
+68.74%4.12B
+0.60%1.18B
-33.41%2.37B
+307.34%3.78B
-36.40%2.44B
+181.29%1.17B
+725.23%3.57B
-36.38%927.00M
-24.71%3.84B
-86.37%417.00M
-85.91%432.00M
+284.43%1.46B
+859.40%5.10B
+22.65%3.06B
+437.89%3.07B
-50.52%379.00M
-73.43%532.00M
+10.84%2.49B
Non-Operating Interest Expense
+31.21%5.90B
+65.26%4.50B
+102.03%4.19B
+0.96%2.83B
+50.46%2.27B
+13.52%2.72B
+206.96%2.07B
+115.28%2.80B
+20.16%1.51B
+39.55%2.40B
+14.60%675.00M
+150.38%1.30B
+363.10%1.26B
+79.60%1.72B
-15.86%589.00M
+46.48%520.00M
-56.64%271.00M
-27.85%956.00M
+73.27%700.00M
+43.15%355.00M
Special Income (Charges)
+307.04%3.70B
+1583.33%909.00M
-100.00%0.00
+783.33%318.00M
+468100.00%9.36B
-68.24%54.00M
-96.15%4.00M
-99.85%36.00M
--2.00M
--170.00M
--104.00M
--24.13B
--0.00
----
----
----
----
----
----
----
-Less:Other Special Charges
-307.04%-3.70B
-1583.33%-909.00M
+100.00%0.00
-783.33%-318.00M
-468100.00%-9.36B
+68.24%-54.00M
+96.15%-4.00M
+99.85%-36.00M
---2.00M
---170.00M
---104.00M
---24.13B
----
----
----
----
----
----
----
----
Pretax Profit
+79.06%90.42B
+7.78%50.50B
-1.64%-48.66B
-71.03%17.31B
-94.00%5.33B
+47.89%46.85B
-355.28%-47.88B
-23.70%59.76B
+66.75%88.80B
-11.59%31.68B
+44.37%-10.52B
+4.23%78.32B
+84.57%53.26B
-40.52%35.83B
-406.62%-18.90B
-3.18%75.14B
-66.08%28.85B
-21.29%60.24B
-82.94%6.17B
-8.20%77.60B
Tax
+70.60%21.99B
-6.04%12.89B
-778.08%-15.38B
-75.34%2.80B
-60.49%6.79B
+99.81%13.72B
+16.89%-1.75B
-34.87%11.35B
+39.29%17.18B
+33.50%6.87B
+67.94%-2.11B
+15.77%17.43B
+91.86%12.33B
-47.64%5.14B
-948.52%-6.58B
-6.52%15.06B
-57.28%6.43B
-45.45%9.83B
-85.67%775.00M
+613.16%16.11B
Net Profit
+81.96%68.42B
+13.50%37.60B
+27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
+33.52%33.13B
-448.52%-46.13B
-20.50%48.41B
+75.02%71.62B
-19.14%24.81B
+31.79%-8.41B
+1.34%60.89B
+82.48%40.92B
-39.13%30.69B
-328.72%-12.33B
-2.30%60.08B
-67.97%22.43B
-13.85%50.41B
-82.46%5.39B
-29.86%61.49B
Profit from Continuing Operations
+81.96%68.42B
+13.50%37.60B
+27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
+33.52%33.13B
-448.58%-46.13B
-20.50%48.41B
+75.02%71.62B
-19.14%24.81B
+31.79%-8.41B
+1.34%60.89B
+82.48%40.92B
-39.13%30.69B
-328.70%-12.33B
-2.30%60.08B
-67.97%22.43B
-13.85%50.41B
-82.46%5.39B
-29.86%61.49B
Net Income to Parent Company
+81.96%68.42B
+13.50%37.60B
+27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
+33.52%33.13B
-448.52%-46.13B
-20.50%48.41B
+75.02%71.62B
-19.14%24.81B
+31.79%-8.41B
+1.34%60.89B
+82.48%40.92B
-39.13%30.69B
-328.72%-12.33B
-2.30%60.08B
-67.97%22.43B
-13.85%50.41B
-82.46%5.39B
-29.86%61.49B
Other Preferred Stock Dividends
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Income to Common Stockholders
+81.96%68.42B
+13.50%37.60B
+27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
+33.52%33.13B
-448.52%-46.13B
-20.50%48.41B
+75.02%71.62B
-19.14%24.81B
+31.79%-8.41B
+1.34%60.89B
+82.48%40.92B
-39.13%30.69B
-328.72%-12.33B
-2.30%60.08B
-67.97%22.43B
-13.85%50.41B
-82.46%5.39B
-29.86%61.49B
Basic EPS
+82.00%38.22
+13.76%21.00
+26.36%-18.55
-69.54%8.09
-102.06%-0.81
+35.84%18.46
-468.62%-25.19
-19.17%26.56
+77.91%39.30
-17.93%13.59
+33.18%-4.43
+1.61%32.86
+83.02%22.09
-38.98%16.56
-307.84%-6.63
-1.40%32.34
-67.49%12.07
-12.54%27.14
-80.57%3.19
-28.13%32.80
Diluted EPS
+82.00%38.11
+13.68%20.94
+26.71%-18.55
-69.64%8.06
-102.06%-0.81
+35.54%18.42
-471.33%-25.31
-19.15%26.55
+77.90%39.28
-17.89%13.59
+33.18%-4.43
+1.58%32.84
+82.93%22.08
-38.97%16.55
-307.84%-6.63
-1.37%32.33
-67.47%12.07
-12.52%27.12
-80.56%3.19
-28.11%32.78
Dividend Per Share
--0.00
--0.00
+16.67%35.00
--0.00
+16.67%35.00
--0.00
+20.00%30.00
--0.00
+20.00%30.00
--0.00
--25.00
--0.00
+19.05%25.00
--0.00
-100.00%0.00
--0.00
+5.00%21.00
--0.00
+5.26%20.00
--0.00
Deadline
Jun 30, 2025
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Accounting Standard
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
NonUS_GAAP
2026/Q12025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q22021/Q12020/Q42020/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 25 (U.S. Eastern Time), sources from the Pakistani military and Iranian security agencies told Sputnik News that the U.S. and Iran Show More